4.6 Article

CV Imaging: What Was New in 2012?

期刊

JACC-CARDIOVASCULAR IMAGING
卷 6, 期 6, 页码 714-734

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jcmg.2013.04.005

关键词

cardiac computed tomography; cardiac magnetic resonance; contrast; coronary angiography; echocardiography; late gadolinium enhancement; PET; SPECT; strain; strain rate

资金

  1. Siemens
  2. Schering
  3. Guerbet
  4. Philips Healthcare
  5. Bayer Healthcare

向作者/读者索取更多资源

Echocardiography, single-photon emission computed tomography (SPECT), positron emission tomography (PET), cardiac magnetic resonance, and cardiac computed tomography can be used for anatomic and functional imaging of the heart. All 4 methods are subject to continuous improvement. Echocardiography benefits from the more widespread availability of 3-dimensional imaging, strain and strain rate analysis, and contrast applications. SPECT imaging continues to provide very valuable prognostic data, and PET imaging, on the one hand, permits quantification of coronary flow reserve, a strong prognostic predictor, and, on the other hand, can be used for molecular imaging, allowing the analysis of extremely small-scale functional alterations in the heart. Magnetic resonance is gaining increasing importance as a stress test, mainly through perfusion imaging, and continues to provide very valuable prognostic information based on late gadolinium enhancement. Magnetic resonance coronary angiography does not substantially contribute to clinical cardiology at this point in time. Computed tomography imaging of the heart mainly concentrates on the imaging of coronary artery lumen and plaque and has made substantial progress regarding outcome data. In this review, the current status of the 5 imaging techniques is illustrated by reviewing pertinent publications of the year 2012. (C) 2013 by the American College of Cardiology Foundation

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据